baber/WOPTO huggingface dataset:
Patent NZ-219897-A (NZ)
Title: Cell line producing a.i.d.s. antigens, virus and methods of detection
Inventor: FOLKS THOMAS M
IPC: C12N5/071
Filed: 1987-04-07
Abstract: Leu-3<-> cells surviving infection with the AIDS retrovirus can be induced with IUdR to express infectious virus. A cellular clone (8E5), isolated by limiting dilution of a mass culture of survivor cells, was found to contain a single, integrated, defective provirus that was constitutively expressed. Although IUdR treatment of 8E5 cells failed to induce infectious virus, cocultivation with Leu-3<+> cells generated the characteristic syncytia associated with acute AIDS retrovirus infection. The single integrated copy of proviral DNA directs the synthesis of all major viral structural proteins except p64 and p34 as monitored by immunoblotting. Diagnostic reagents and kits in accordance with the present invention are also described.
Patent NZ-228297-A (NZ)
Title: Method of sizing paper using rosin or resin-based sizing agent at neutral or alkaline ph with simultaneous addition of aluminium compound; paper sizing composition and sized paper
Inventor: HISKENS IAN RICHARD
IPC: D21H17/62
Filed: 1989-03-10
Abstract: The manufacture of sized paper, by adding a sizing agent and an aluminium compound to paper-making stock or by surface-sizing paper with a pre-blend of the agent and the compound, is carried out at a neutral or alkaline pH, typically a pH above 6, and so that the agent and the compound are added simultaneously to the paper-making stock or are applied simultaneously to the paper surface. If the agent and the compound are used as a one-shot pre-blend, this is made on or immediately before use.
Patent NZ-234312-A (NZ)
Title: Reduction of sterol content in dairy products by treatment with cyclodextrin
Inventor: GRAILLE JEAN
IPC: A23L5/20
Filed: 1990-06-29
Abstract: The present invention relates to a process for preparing milk products with reduced sterol content and, in particular, reduced cholesterol content, characterised in that it essentially consists in bringing into contact an oil-in-water emulsion comprising fats of dairy origin with cyclodextrin in a sufficient quantity to form inclusion complexes with the sterols so that the latter may be removed from the fat and, in a simultaneous manner or otherwise, in at least partially separating the said complexes from the medium without inverting the starting oil-in-water emulsion.
Patent NZ-238484-A (NZ)
Title: Hydrogenation of aromatics and sulphur compounds in a high boiling range feedstock using catalyst containing ni and w, then catalyst containing mo and ni or co
Inventor: BHAN OPINDER KISHEN
IPC: F02B3/06
Filed: 1991-06-11
Abstract: In a process for the concomitant hydrogenation of aromatics and sulphur-bearing hydrocarbons in an aromatics- and sulphur-bearing, diesel boiling-range hydrocarbon feedstock, the feedstock is contacted at a temperature between 315 and 399  DEG C and a pressure between 40 and 168 bar in the presence of added hydrogen with a first catalyst bed containing a hydrotreating catalyst containing nickel, tungsten and optionally phosphorous supported on an alumina support, and, after contact with the first catalyst bed, the hydrogen and feedstock without modification, is passed from the first catalyst bed to a second catalyst bed where it is contacted at a temperature between 315 and 399  DEG C and a pressure between 40 and 168 bar with a hydrotreating catalyst containing cobalt and/or nickel, molybdenum and optionally phosphorous supported on an alumina support.
Patent NZ-240086-A (NZ)
Title: Hydrophilic adsorbent prepared by reacting an epoxy resin, an amino-terminated poly-(alkylene oxide), and a polyfunctional aliphatic amine.
Inventor: DABI SHMUEL
IPC: A61L15/42
Filed: 1991-10-03
Abstract: Improved hydrophilic materials, such as foams and films, are provided. These material find use in a wide variety of fluid absorbent products, especially those relating to the absorption of bodily fluids. The soft, absorbent, and resilient foams of this invention exhibit greater wet and dry mechanical strength when compared with those known in the art, as well as improved fluid wicking capacity and lower density. These improved properties are believed attributable to the incorporation into the foams of at least one polyfunctional aliphatic amine. The provided hydrophilic materials comprise the polymeric reaction product of a mixture which comprises at least one epoxy resin, at least one amine-terminated poly(alkylene oxide), and at least one polyfunctional aliphatic amine. Methods for preparing foams and other hydrophilic materials are also provided. In general, hydrophilic materials are prepared by providing at least one epoxy resin, forming a reaction mixture by contacting the epoxy resin with at least one amine-terminated poly(alkylene oxide) and at least one polyfunctional aliphatic amine, and curing the reaction mixture.
Patent NZ-242758-A (NZ)
Title: Alpha-phenylacrylic acid derivatives, pesticidal-fungicidal compositions and preparation thereof
Inventor: GRAMMENOS WASSILIOS
IPC: A01N43/56
Filed: 1992-05-15
Abstract: alpha -Phenylacrylic acid derivatives I <IMAGE>  in which     n = 0 to 4;   y = 0 or 1; R<1> = H; alkyl; alkenyl; alkynyl; optionally substituted cycloalkyl; vinyl or ethynyl if W represents a direct bond; R<2> = CN; alkenyl; alkynyl; optionally substituted cycloalkyl; optionally substituted alkyl; R<3> = H; NO2; CN; halogen; alkyl; alkoxy; haloalkyl; haloalkoxy; alkylthio; or, in the event that n represents 2, 3 or 4, two adjacent substituents R<3> together are optionally substituted 1,3-butadiene-1,4-diyl; R<4> = H; CHO; optionally substituted alkyl; optionally substituted alkenyl; optionally substituted alkynyl; an optionally substituted saturated or unsaturated cyclic radical; (phenyl)3P-; (phenyl)2PO-; (alkoxy)2PO-; an optionally substituted (hetero)aromatic system; W = a direct bond; oxygen; sulphur; optionally substituted nitrogen;   A = -O-; -C(=O)-; -O-C(=O)-; -C(=O)-O-; -S-; -S(=O)-; -O-S(=0)--S(=O)-O-; -S(=O)2-; -O-S(=O)2-; -S(=O)2-O-; -NR<5>-; -O-NR<5>-; -NR<5>-C(=O)-; -C(=O)-NR<5>-; -NR<5>-C(=O)-NR<6>-; -NR<5>-S(=O)-; -S(=O)-NR<5>-; -NR<5>-S-(=O)-NR<6>-; -NR<5>-S(=O)2-; -S(=O)2-NR<5>-; -NR<5>-S(=O)2-NR<6>-; -N=N-; -NR<5>-NR<6>-; -NR<5>-NR<6>-C(=O)-; -C(=O)-NR<5>-NR<6>-; -NR<5>-NR<6>-S(=O)-; -S(=O)-NR<5>-NR<6>-; -NR<5>-NR<6>-S(=O)2-; -S(=O)2-NR<5>-NR<6>-; -O-(alkylene)-O-; -C-(=O)-(alkylene)-O-; -O-C(=O)-(alkylene)-O-; -C(=O)-O-(alkylene)-O-; -S-(alkylene)-O-; -S(=0)2-(alkylene)-O-; -O-S-(=O)2-(alkylene)-O-; -S(=O)2-O-(alkylene)-O-; -NR<5>-(alkylene)-O-; -O-NR<5>-(alkylene)-O-; -NR<5>-C(=O)-(alkylene)-O-; -C(=O)-NR<5>-(alkylene)-O-; -NR<5>-C(=O)-NR<6>-(alkylene)-O-; -N=N-(alkylene)-O-; -NR<5>-NR<6>-(alkylene)-O-; -NR<5>-NR<6>-C(=O)-(alkylene)-O-; -C(=O)-NR<5>-NR<6>-(alkylene)-O-; optionally substituted alkylene, alkenylene or alkynylene, it being possible for these carbon chains to be interrupted by one of the following groups or to be bonded to R<4> or to the phenyl ring by one of the following groups: O, S, NR<5>, CO, CO-O, O-CO, SO, SO2, SO2-O, O-SO2, NR<5>-CO, CO-NR<5>, NR<5>-CO-NR<6>, N=N, NR<5>-NR<6>, NR<5>-NR<6>-CO, CO-NR<5>-NR<6>;   R<5>, R<6> = H, alkyl or alkoxy, their preparation, fungicides and pesticides containing them, and their use.
Patent NZ-245471-A (NZ)
Title: Foamable composition comprising a resin and an alpha,beta-hydroxylated hydrocarbon azide blowing agent, preparation and articles thereof
Inventor: BEDEL DIDIER
IPC: C08J9/10
Filed: 1992-12-14
Abstract: Composition capable of being converted into foam, comprising a mixture based on polymeric resin and an effective quantity, in relation to the said resin, of blowing agent. The blowing agent comprises at least one  alpha , beta -hydroxylated hydrocarbon azide.   Application to the production of articles made of synthetic foam.
Patent NZ-274912-A (NZ)
Title: Process for the alkylation of amino acids
Inventor: PATEL RAJESHKUMAR NATWARLAL
IPC: C07C227/40
Filed: 1994-11-02
Abstract: This invention provides improvements in certain processes for alkylating amino acids whereby yields based on amino acid are improved. More specifically, the invention provides a process for the preparation of amino acid derivatives in free acid or salt form, in which the nitrogen atoms of two or more amino acid molecules are linked by a hydrocarbyl or substituted hydrocarbyl group, which process includes a reaction step comprising reacting, in an aqueous medium at a pH in the range 7-14, a compound of the formula X-A-Y where X and Y are halo atoms which may be the same or different and A is a hydrocarbyl or substituted hydrocarbyl group, in which X and Y are attached to aliphatic or cycloaliphatic carbon atoms, with an amino acid (or salt thereof); wherein the process includes the step of recovering unreacted amino acid and recycling it to the reaction step.
Patent NZ-282810-A (NZ)
Title: 7-(4-(4-fluorobenzoyl)-piperidin-1-ylpropyloxy)- chromen-4-one derivatives; pharmaceutical compositions
Inventor: FOGUET RAFAEL
IPC: A61K31/445
Filed: 1995-03-17
Abstract: PCT No. PCT/EP95/01008 Sec. 371 Date Dec. 12, 1995 Sec. 102(e) Date Dec. 12, 1995 PCT Filed Mar. 17, 1995 PCT Pub. No. WO95/25733 PCT Pub. Date Sep. 28, 1995The present invention relates to new chromene compounds of the general formula (I):   <IMAGE>om 1 to 4 carbon atoms, halogen, trifluoromethyl, optionally substituted phenyl, or hydroxymethyl, as well as their pharmaceutically acceptable addition salts. These compounds are useful in the treatment of psychosis and schizophrenia.
Patent NZ-290810-A (NZ)
Title: Oligomer carrier molecules with selectively incorporated marker and hapten groups
Inventor: JOSEL HANS-PETER
IPC: G01N33/53
Filed: 1995-07-24
Abstract: The present invention concerns novel conjugates, process for manufacturing them, and the use of such conjugates as antigens in immunological detection processes or in DNA diagnostic procedures.
Patent NZ-305228-A (NZ)
Title: Pharmaceutical compositions containing mercapto and seleno guanidine derivatives
Inventor: SOUTHAN GARRY J
IPC: A61P25/28
Filed: 1996-03-22
Abstract: This invention is directed to a pharmacologically acceptable composition for inhibiting nitric oxide synthase in a mammal, which includes a mercapto or seleno derivative and a pharmaceutically acceptable carrier. The invention also concerns a method of inhibiting nitric oxide synthase, selectively inhibiting the inducible isoform of nitric oxide synthase, and treating various conditions where there is an advantage in inhibiting nitric oxide biosynthesis. The method includes the step of administering to a mammal a mercapto or seleno derivative in pure form or in a pharmaceutically acceptable carrier.
Patent NZ-305708-A (NZ)
Title: Proton pump inhibitors in the form of a paste suitable for the treatment of gastric acid related diseases
Inventor: DAVE KAUSHIK J
IPC: A61K9/00
Filed: 1996-03-29
Abstract: The present invention is concerned with an oral pharmaceutical formulation containing a proton pump inhibitor (PPI) which is suitable for the treatment of gastric acid related diseases in man and animals. More specifically, the composition is a paste, and is particularly suitable for delivery of a proton pump inhibitor to horses.
Patent NZ-310000-A (NZ)
Title: Bisphosphonates (alendronate) for the prevention of bone loss
Inventor: DAIFOTIS ANASTASIA G
IPC: A61P43/00
Filed: 1996-06-03
Abstract: The use of compounds described as bisphosphonates selected from the group consisting of: alendronate, etidronate (1-hydroxy-ethidene-bisphosphonic acid), pamidronate (3-amino-1-hydroxypropyildiene-1,1-diphosphanate), risedronate (2-(3-pyridinyl)-1-hydroxyethylidene-bisphosphonic acid), clodronate (dichloromethylene-bisphosphonic acid), tiludronate (chloro-4-phenylthiomethylidene-bisphosphonic acid), ibandronic acid (1-hydroxy-3-(methylpentylamino)-propylidene-bisphosphonic acid and pharmaceutically acceptable salts thereof for treating or preventing bone loss associated with immunosuppressive therapy.
Patent NZ-333152-A (NZ)
Title: Liquid crystal detergent compositions containing a glycerol ether cosurfactant, a sulphonate compound and an abrasive
Inventor: ERILLI RITA
IPC: C11D1/37
Filed: 1997-06-04
Abstract: A liquid crystal detergent composition comprising by weight: a) 15 to 30% sodium C10-20 paraffin sulfonate, C8-16 alkyl benzene sulfonate or a C10-24 olefin sulfonate b) 2-20% water soluble salt of ethoxylated C8-18 alkyl ether sulfate surfactant; c) 1-10% abrasive d) 2-15% glycol ether cosurfactant e) 0-6% magnesium salt f) 4-10% water insoluble organic compound selected from the group consisting of perfumes, essential oils and water insoluble hydrocarbons having from 8-18 carbon atoms and g) the balance being water the liquid crystal detergent composition does not contain nonionic surfactant and has storage modulus measured at a temperature between 20 degrees to 40 degrees, at a strain of 0.1% to 5% and a frequency of 10 radians/second of at least one Pascal.
Patent NZ-336388-A (NZ)
Title: Weather seal for junction of chimney with roof
Inventor: HAYNES ANDREW LEO
IPC: E04F13/14
Filed: 1999-06-23
Abstract: The specification describes a seal for sealing the joins between a surface and a member extending from the surface.  The seal has a tapered flexible sleeve with an inner and outer skin.  A first aperture is adapted to contact the seal against the exterior of the member via a rib on the inner skin.  The rib is able to form a weatherproof seal at any angle the extending member takes.
Patent NZ-337100-A (NZ)
Title: Tray for a wet shaving razor characterised by a removable transparent platform member from the base
Inventor: GRAY MICHAEL J
IPC: A45D27/29
Filed: 1998-02-18
Abstract: A tray (10) for a razor (12) that includes a base member and a platform member. The base member includes an engagement structure (26, 28) for releasably holding the razor and platform support structure (34, 36). The platform member is supported on the platform support structure, is secured to the base member, and is located behind at least part of a razor when the razor is held by the engagement structure.
Patent NZ-337122-A (NZ)
Title: CETP activity inhibitor and it's use in the prophylactic and therapeutic treatment of atherosclerosis and hyperlipidemia
Inventor: SHINKAI HISASHI
IPC: C07C327/30
Filed: 1998-02-10
Abstract: The present invention provides a CETP activity inhibitor comprising as an active ingredient a compound represented by the formula (I):   
wherein R represents a straight chain or branched alkyl group; a straight chain or branched alkenyl group; a lower haloalkyl group; a substituted orunsubstituted cycloalkyl group; a substituted or unsubstituted cycloalkenyl group; a substituted or unsubstituted cycloalkylalkyl group; a substituted or unsubstituted aryl group, or a substituted or unsubstituted heterocyclic group, X 1 , X 2 , X 3 , and X, may be the same or different and each represents a hydrogen atom, a halogen atom, a lower alkyl group, a lower haloalkyl group; a lower alkoxy group; a cyano group; a nitro group; an acyl group; or an aryl group, Y represents -CO- or -SO 2 -, and Z represents a hydrogen atom or a mercapto-protecting group, or a prodrug compound, a pharmaceutically acceptable salt, or hydrate or solvate thereof. The compounds represented by the formula (I) can increase HDL and at the same time decrease LDL through selective inhibition of CETP activity and, therefore, is expected to be useful as a new type of a preventive or therapeutic agent for atherosclerosis or hyperlipidemia.
Patent NZ-502620-A (NZ)
Title: Methods and compositions for controlling biofouling using amino methyl phosphonic acids
Inventor: VUNK GRACIELA H
IPC: C02F1/50
Filed: 1998-07-27
Abstract: Described is a method to inhibit bacteria from adhering to a submergible metal surface within an aqueous system, comprising the step of contacting the submergible surface with an amino methyl phosphonic acid or a salt thereof. The amino methyl phosphonic acid is a compound of the formula R1R2NCH2P(O)(OH)2, wherein, R1 and R2 are independently a C6-C14 alkyl group or H, but R1 and R2 are not both H, and the salt of an amino methyl phosphonic acid is an acid salt or quaternized acid salt. The method is suitable for submergible surfaces such as a ship hull, a boat hull, a marine structure, a tooth surface or a medical implant surface.
Patent NZ-505666-A (NZ)
Title: 1,2,3,4-tetrahydronaphthalene and 1,2,3,4-tetrahydro-2-naphthalenol derivatives and pharmaceuticals thereof, and their use as potassium channel inhibitors useful for treating cardiac arrhythmias
Inventor: GROSS MICHAEL F
IPC: C07D213/40
Filed: 1999-01-27
Abstract: A compound of formula (I), wherein: t is 1, or 2; A and B are each H; or taken together form a bond between the substituted carbons. R1 is H; alkyl; or is optionally substituted aryl, heteroaryl, heterocyclyl or carbocycloalkyl, with the proviso that when R1 is an optionally substituted aryl, then R1 is not a dialkoxyphenyl. Y2 is (CH2)q; (CH2)wO; HC=CH; or ethynyl; with the proviso that if Y2 is (CH2)q and q=0, then R1 cannot be H. X2 is C=0, C=S, or S02; with the proviso that if Y2 is (CH2)wO, then X2 is not SO2. R3 is H; alkyl; or optionally substituted aryl, aralkyl, heteroaryl, heteroaralkyl; heterocyclyl, carbocycloalkyl; or an alkylene-(substituted amino). Z is H; alkyl; alkyenyl; alkylene(heterocyclyl); alkylene (heteroaryl); alkylene-NHC(O)(alkyl); alkylene-NHC(O)(aryl); alkylene-NHC(O)(heterocyclyl); alkylene-NHC(O)(heteroaryl); alkylene-NHC(O)-(alkylene-heterocyclyl); alkylene-NHC(O)-(heteroaralkyl); alkylene-C(O)(alkyl); alkylene-C(O)O(alkyl); OR14; SR14; or NR15R16. R2 is H; alkyl; optionally substituted aryl, aralkyl, heteroaryl, heterocyclyl, heteroaralkyl, carbocycloalkyl; Ra-O-; or RbRc-N-. Y1 is (CH2)p; CHR17(CH2)o; HC=CH; or ethynyl; X1 is C=O; C=S; SO2; or (CH2)n. R4 is H; alkyl; optionally substituted aryl, aralkyl, heteroaryl, heteroaralkyl; heterocyclyl, carbocycloalkyl; or alkylene-(substituted amino). With the provisos that: (i) If Y1 is (CH2)p, p is 0 and X1 is not (CH2)n then R2 is not H, (ii) If R2 is Ra-O and Y1 is (CH2)p with p=0, then X1 is not SO2 and (iii) If Z is not H, OR14, SR14 or NR15R16, then X2 must be SO2. Also described is a pharmaceutical composition comprising the compound of formula (I) and a pharmaceutically acceptable diluent or carrier. The compounds of formula (I) are useful for inhibiting potassium transport across cellular membranes possessing potassium channels. The compounds of formula (I) are particularly useful for treating cardiac arrhythmias.
Patent NZ-506364-A (NZ)
Title: Swimming pool attachment consisting of fountain nozzle attachment for pump outlet, typically for swimming pool
Inventor: GOODWIN-KNOL EDZER JOHN
IPC: B05B17/08
Filed: 2000-08-17
Abstract: Disclosed is a fountain attachment for a swimming pool, which includes a body 1 formed from a single rigid length of material, a connector (not shown) to connect to the outlet of a pump integrated with a swimming pool, with the body elevates an outlet port adapted to spray liquid.
Patent NZ-512941-A (NZ)
Title: Length polymorphisms in microsatellite (simple sequence repeat - SSR) DNA markers and their use as genetic markers in pine
Inventor: ECHT CRAIG S
IPC: C12Q1/68
Filed: 2000-01-06
Abstract: Microsatellite, simple sequence repeat (SSR),  markers have  much  potential  for  enhancing  genome  mapping   and genotype  identification research  in  forest  genetics  and tree  breeding. SSR markers were developed by isolating  and sequencing 1539 loblolly pine SSR clones for 11 SSR  motifs. After  screening  out redundancy among  the  sequences,  566 oligonucleotide  PCR  primer pairs flanking  the  SSRs  were synthesised  and  evaluated for  their  ability  to  amplify genomic  DNA from loblolly pine.  The three SSR motifs  that yielded  the highest proportion of informative markers  from sequenced   clones   were  (AC)n,  (AAAT)n,   and   (AAAC)n. Eighteen polymorphic tri- and tetranucleotide SSR loci  were genotyped   in  20  loblolly  pine  trees  using   automated fluorescent marker analysis.  The average number of  alleles per  locus  observed  was 6.4, and the average  polymorphism information  content (PIC) was 0.547.  Subsets  of  the  566 primer  pairs  were evaluated for their ability  to  amplify DNA  from  six  other  pine species,  and  54  primer  pairs amplified  markers that were polymorphic among the  species. Also  described are the methods of using the identified  SSR loci as genetic markers.
Patent NZ-515167-A (NZ)
Title: Thiazolidinedione derivative and its use as antidiabetic
Inventor: BLACKLER PAUL DAVID JAMES
IPC: A61P/
Filed: 2000-04-19
Abstract: A polymorphic form of 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ehoxy]benzyl]thiazolidine-2,4-dione,maleic acid salt (the Polymorph) characterized in that it provides: (i) an infra red spectrum containing peaks as 1752, 1546, 1154, 621, and 602 c-1; and/or (ii) a Raman spectrum containing peaks at 1751, 1243 and 602 cm-1; and/or (iii) a solid-state nuclear magnetic resonance spectrum containing peaks at 111.9, 111.4, 119.6, 129.2, 134.0 138.0, 144.7, 153.2, 157.1, 170.7, 172.0 and 175.0 ppm; and/or (iv) an X-ray powder diffraction (XRPD) pattern which gives calculated lattice spacings of 6.46, 5.39, 4.83, 4.68, 3.71, 3.63, 3.58, and 3.48 Angstroms; said polymorph is useful for treating diabetes mellitus and related disorders.
Patent NZ-523538-A (NZ)
Title: Modification of plant resistance to diseases and/or pests
Inventor: SPANGENBERG GERMAN
IPC: C12N9/10
Filed: 2001-07-27
Abstract: A method of increasing resistance of plants to diseases and/or pests, through using the caffeic acid/caffeate O-methyltransferase homologue (OMTH) gene to modify lignin biosynthesis in plants. Optionally the gene is from a ryegrass (Lolium) species. Also disclosed are vectors useful in such methods, transformed plants with increased resistance to diseases and/or pests, and plant cells, seeds and other parts of such plants.
Patent NZ-523946-A (NZ)
Title: Portable hygiene compositions comprising a semi-solid gel and active ingredients in bead form for use in personal oral, dental or skin care
Inventor: ALEXANDER CARL ERNEST
IPC: A61Q5/00
Filed: 2003-01-31
Abstract: Mixing a controlled amount of agar with regular oral, dental or skin hygiene compositions allows manufacture of homogeneous, semi-solid single-use lumps or beads. Agar or analogous structural gelling agents confer sufficient rigidity and a sufficiently high melting point for storage, yet allow disruption of the bead on the skin or in the mouth without residues. Dental or skin care packs hold sufficient beads and optionally a disposable brush. Blister packs (124) carry cast in situ beads or one or a variety of active compositions. Shape, colour and flavour variations (124C) motivate children towards dental care.
Patent NZ-525830-A (NZ)
Title: Disease prevention by reactivation of the thymus
Inventor: BOYD RICHARD
IPC: A61K35/14
Filed: 2001-10-12
Abstract: Disclosed herein are methods for gene therapy utilizing hematopoietic stem cells, lymphoid progenitor cells, and/or myeloid progenitor cells. The cells are genetically modified to provide a gene that is expressed in these cells and their progeny after differentiation. In a preferred embodiment the cells contain a gene or gene fragment that confers to the cells resistance to HIV infection and/or replication. The cells are administered to a patient in conjunction with treatment to reactivate the patient's thymus. The cells may be autologous, syngeneic, allogeneic or xenogeneic, as tolerance to foreign cells is created in the patient during reactivation of the thymus. In a preferred embodiment the hematopoietic stem cells are CD34+. The patient's thymus is reactivated by disruption of sex steroid mediated signaling to the thymus. In a preferred embodiment, this disruption is created by administration of LHRH agonists, LHRH antagonists, anti-LHRH receptor antibodies, anti-LHRH vaccines or combinations thereof.